GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Azenta Inc (FRA:BA3) » Definitions » Debt-to-Equity

Azenta (FRA:BA3) Debt-to-Equity : 0.03 (As of Dec. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Azenta Debt-to-Equity?

Azenta's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €0.0 Mil. Azenta's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €51.9 Mil. Azenta's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €1,641.6 Mil. Azenta's debt to equity for the quarter that ended in Dec. 2024 was 0.03.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Azenta's Debt-to-Equity or its related term are showing as below:

FRA:BA3' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01   Med: 0.06   Max: 0.75
Current: 0.03

During the past 13 years, the highest Debt-to-Equity Ratio of Azenta was 0.75. The lowest was 0.01. And the median was 0.06.

FRA:BA3's Debt-to-Equity is ranked better than
88.05% of 686 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs FRA:BA3: 0.03

Azenta Debt-to-Equity Historical Data

The historical data trend for Azenta's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Azenta Debt-to-Equity Chart

Azenta Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.07 0.02 0.02 0.03

Azenta Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.04 0.03 0.03

Competitive Comparison of Azenta's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Azenta's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Azenta's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Azenta's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Azenta's Debt-to-Equity falls into.


;
;

Azenta Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Azenta's Debt to Equity Ratio for the fiscal year that ended in Sep. 2024 is calculated as

Azenta's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Azenta  (FRA:BA3) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Azenta Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Azenta's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Azenta Business Description

Traded in Other Exchanges
Address
200 Summit Drive, 6th Floor, Burlington, MA, USA, 01803
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

Azenta Headlines

No Headlines